Insights

Capturing Patients Diversity as the Next Challenge in Drug Development? Insights from IASP 2024 

September 10, 2024

Earlier this month, the IASP (International Association for the Study of Pain) meeting marked a significant moment in honoring the vision of Professor John Bonica founder of IASP. In 1973, Professor Bonica successfully convened a group of experts in Issaquah, Washington, to chart a path forward for improving the lives of patients suffering from pain.

Read More

How Cognivia Turns Traits Into Data with a Validated Questionnaire & Machine Learning

August 2, 2024

Learn more about the development of the MPsQ and the its use as part of the Placebell©™ technology.

Read More

Pain: the Tree that Hides the Forest of Symptoms

June 3, 2024

The 2024 International Osteoarthritis Research Society (OARSI) conference concluded last week, offering valuable exchange and information. What insights could we gather from these dynamic four days? One of the most interesting themes was the relationship between patients’ osteoarthritis (OA), pain, and psychosocial state – a crucial but often overlooked topic. Indeed, OA studies typically assess

Read More

Global Reach, Local Understanding: Cognivia’s Participant Questionnaire Validated in Over 50 Languages for Comprehensive Clinical Trials 

February 20, 2024

For high quality clinical trial data, the voice of the participant (i.e. patient and/or caregiver) must be captured in the language that they can understand. In this blog post, we discuss the linguistic validation process of the participant questionnaire behind Cognivia’s clinical trial technology.

Read More

Expectations of Improvement in Clinical Trials: site or patient related?

July 29, 2023

There are multiple techniques to account for these expectations in studies, including site stafftraining, subject training before the start of the study, and applying  an adjustment covariate.

Read More

The FDA highlights the tools to enhance the precision of primary analyses in clinical trials.

June 5, 2023

The FDA released its final guidance regarding the use of covariates to improve the precision of statistical analyses in clinical trials on 26 May 2023. It is a major step forward in the statistical analysis of clinical trial data. Recognizing that nearly a decade ago, the publication of the EMA guide initiated the movement, the FDA has crystallized the concept with the current guidance.

Read More